New cystic fibrosis drug under watchful eye after prior treatment troubles
NCT ID NCT06683092
First seen Nov 03, 2025 · Last updated May 16, 2026 · Updated 26 times
Summary
This study follows about 200 people with cystic fibrosis, ages 6 and up, who are starting a new triple therapy (VTD) after experiencing mental health issues or liver injury from a previous drug (ETI). Researchers will closely monitor for any return of mental health symptoms or liver problems over one year. The goal is to understand how safe and tolerable the new treatment is for this specific group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Boston Children's Hospital
RECRUITINGBoston, Massachusetts, 02215, United States
Contact
Contact
Contact Email: •••••@•••••
-
Children's Hospital Colorado
RECRUITINGAurora, Colorado, 80045, United States
Contact Email: •••••@•••••
Contact
-
Emory University
RECRUITINGAtlanta, Georgia, 30322, United States
Contact Email: •••••@•••••
Contact
Contact
-
Indiana University
RECRUITINGBloomington, Indiana, 47405, United States
Contact
Contact Email: •••••@•••••
Contact
-
Johns Hopkins University
RECRUITINGBaltimore, Maryland, 21287, United States
Contact Email: •••••@•••••
Contact
-
Kansas University Medical Center
RECRUITINGKansas City, Kansas, 66160, United States
Contact
Contact Email: •••••@•••••
Contact Email: •••••@•••••
-
Massachusetts General Hospital
NOT_YET_RECRUITINGBoston, Massachusetts, 02114, United States
Contact
Contact Email: •••••@•••••
Contact
-
National Jewish Health
RECRUITINGDenver, Colorado, 80206, United States
Contact
Contact Email: •••••@•••••
-
Nemours Children's
RECRUITINGWilmington, Delaware, 19803, United States
Contact
Contact
Contact Email: •••••@•••••
-
Nemours Children's
RECRUITINGJacksonville, Florida, 32207, United States
Contact
Contact Email: •••••@•••••
Contact
-
Nemours Children's
RECRUITINGOrlando, Florida, 32827, United States
Contact
Contact
Contact Email: •••••@•••••
-
Nemours Children's
RECRUITINGPensacola, Florida, 32514, United States
Contact
Contact
Contact Email: •••••@•••••
-
Seattle Children's Hospital
RECRUITINGSeattle, Washington, 98105, United States
Contact
Contact Email: •••••@•••••
-
University of Alabama at Birmingham
RECRUITINGBirmingham, Alabama, 35233, United States
Contact
Contact Email: •••••@•••••
-
University of Michigan
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact Email: •••••@•••••
Contact
Contact
-
University of Pittsburgh Medical Center
RECRUITINGPittsburgh, Pennsylvania, 15224, United States
Contact Email: •••••@•••••
Contact
-
University of Texas Southwestern Medical Center
RECRUITINGDallas, Texas, 75235, United States
Contact
Contact Email: •••••@•••••
Contact
-
Washington University at St. Louis
NOT_YET_RECRUITINGSt Louis, Missouri, 63130, United States
Contact
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.